Cargando…
Correction to: Andexanet Alfa: First Global Approval
Autor principal: | Heo, Young-A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132450/ https://www.ncbi.nlm.nih.gov/pubmed/30032379 http://dx.doi.org/10.1007/s40265-018-0954-y |
Ejemplares similares
-
Andexanet Alfa: First Global Approval
por: Heo, Young-A
Publicado: (2018) -
Correction to: Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA
por: Heo, Young-A
Publicado: (2018) -
Correction to: Efanesoctocog Alfa: First Approval
por: Keam, Susan J.
Publicado: (2023) -
Correction to: Revefenacin: First Global Approval
por: Heo, Young-A
Publicado: (2019) -
Institutional Experience of Using Andexanet Alfa
por: Khadka, Sushmita, et al.
Publicado: (2020)